title: Serum insulin and leptin levels and valproate-associated obesity.
authors.forename: Alberto
authors.initials: A
authors.lastname: Verrotti
authors.forename: Giovanna
authors.initials: G
authors.lastname: di Corcia
authors.forename: Carmela
authors.initials: C
authors.lastname: Salladini
authors.forename: Daniela
authors.initials: D
authors.lastname: Trotta
authors.forename: Guido
authors.initials: G
authors.lastname: Morgese
authors.forename: Francesco
authors.initials: F
authors.lastname: Chiarelli
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001823:Body Composition / Q000502:physiology; D015992:Body Mass Index; D002648:Child; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D005246:Feedback / Q000502:physiology; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D020738:Leptin / Q000097:blood*; D008297:Male; D009765:Obesity / Q000097:blood / Q000139:chemically induced*; D012307:Risk Factors; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D007328:Insulin; D020738:Leptin; D014635:Valproic Acid